Ultrasound and microbubble-assisted gene delivery: Recent advances and ongoing challenges

Therapeutic Delivery

Volumn 3, Issue 10, 2012, Pages 1199-1215

  Delalande, Anthony ^a,b   Postema, Michiel ^a   Mignet, Nathalie ^c   Midoux, Patrick ^d   Pichon, Chantal ^d  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c CNRS   (France)

^d CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 11; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 9; HYDROGEN PEROXIDE; INTERLEUKIN 12; LIPOSOME; MACROGOL; PARVOVIRUS VECTOR; PERFLEXANE; PERFLUBUTANE; PERFLUTREN; PLASMID DNA; PROTEIN P53; SCATTER FACTOR; SONOVUE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 165;

ANGIOGENIC GENE THERAPY; ARTERY INTIMA PROLIFERATION; BONE DEFECT; BONE DENSITY; BONE REGENERATION; CANCER GENE THERAPY; CELL INTERACTION; CELL PERMEABILIZATION; CONJUGATION; CONTRAST ENHANCEMENT; ELECTROPORATION; EMULSION; ENCAPSULATION; ENDOCYTOSIS; HEART INFARCTION; HINDLIMB; HUMAN; LIMB ISCHEMIA; MICROBUBBLE; MOLECULAR IMAGING; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RESTENOSIS; RETINA GANGLION CELL; REVIEW; SONOPORATION; STATIC ELECTRICITY; ULTRASOUND;

EID: 84867927729     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.100     Document Type: Review

References (151)

1. Raper SE, Chirmule N, Lee FS et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80(1-2), 148-158 (2003).
2. Hacein-Bey-Abina S, von Kalle C, Schmidt M et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348(3), 255-256 (2003).
3. Mahato RI. Non-viral peptide-based approaches to gene delivery. J. Drug Target. 7(4), 249-268 (1999).
4. Midoux P, Pichon C, Yaouanc JJ, Jaffres PA. Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br. J. Pharm. 157(2), 166-178 (2009).
5. Wagner E, Ogris M, Zauner W. Polylysine-based transfection systems utilizing receptor-mediated delivery. Adv. Drug Deliv. Rev. 30(1-3), 97-113 (1998).
6. Glover DJ. Artificial viruses: exploiting viral trafficking for therapeutics. Infect Disord. Drug Targets. 12(1), 68-80 (2011).
7. Miyata K, Nishiyama N, Kataoka K. Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses. Chem. Soc. Rev. 41(7), 2562-2574 (2012).
8. Wagner E. Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise. Acc Chem Res. 45 (7), 1005-1013 (2011).
9. Mitragotri S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat. Rev. Drug Discov. 4(3), 255-260 (2005).
10. Lindner Jr. Molecular imaging with contrast ultrasound and targeted microbubbles. J. Nucl. Cardiol. 11(2), 215-221 (2004).
11. Wood RW, Loomis AL. The physical and biological effects of high-frequency sound-waves of great intensity. Philos. Mag. 4(22), 417-436 (1927).
12. Fechheimer M, Boylan JF, Parker S, Sisken JE, Patel GL, Zimmer SG. Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading. Proc. Natl Acad. Sci. USA 84(23), 8463-8467 (1987).
13. Tachibana K, Tachibana S. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation 92(5), 1148-1150 (1995).
14. Barnett SB, Ter Haar GR, Ziskin MC, Rott HD, Duck FA, Maeda K. International recommendations and guidelines for the safe use of diagnostic ultrasound in medicine. Ultrasound Med. Biol. 26(3), 355-366 (2000).
15. Kinoshita M, McDannold N, Jolesz FA, Hynynen K. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochem. Biophys. Res. Commun. 340(4), 1085-1090 (2006).
16. Frenkel V. Ultrasound mediated delivery of drugs and genes to solid tumors. Adv. Drug Deliv. Rev. 60(10), 1193-1208 (2008).
17. Kost J, Leong K, Langer R. Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc. Natl Acad. Sci. USA 86(20), 7663-7666 (1989).
18. O'Neill BE, Li KC. Augmentation of targeted delivery with pulsed high intensity focused ultrasound. Int. J. Hyperthermia 24(6), 506-520 (2008).
19. Rapoport N, Gao Z, Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J. Natl Cancer Inst. 99(14), 1095-1106 (2007).
20. Schroeder A, Avnir Y, Weisman S et al. Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility. Langmuir 23(7), 4019-4025 (2007).
21. Schroeder A, Kost J, Barenholz Y. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes. Chem. Phys. Lipids 162(1-2), 1-16 (2009).
22. Lide DR. Speed of sound in various media. In: CRC Handbook of Chemistry and Physics (84th Edition). CRC Press, Boca Raton, FL, USA (2003).
23. Goss SA, Frizzell LA, Dunn F. Ultrasonic absorption and attenuation in mammalian tissues. Ultrasound Med. Biol. 5(2), 181-186 (1979).
24. Postema M. Fundamentals of Medical Ultrasonics. Spon Press, London, UK (2011).
25. Postema M, Gilja OH. Contrast-enhanced and targeted ultrasound. World J. Gastroenterol. 17(1), 28-41 (2011).
26. Morgan KE, Allen JS, Dayton PA, Chomas JE, Klibaov AL, Ferrara KW. Experimental and theoretical evaluation of microbubble behavior: effect of transmitted phase and bubble size. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 47(6), 1494-1509 (2000).
27. Dayton PA, Morgan KE, Klibanov AL, Brandenburger GH, Ferrara KW. Optical and acoustical observations of the effects of ultrasound on contrast agents. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 46(1), 220-232 (1999).
28. Wu J, Nyborg WL. Ultrasound, cavitation bubbles and their interaction with cells. Adv. Drug Deliv. Rev. 60(10), 1103-1116 (2008).
29. Postema M, Kotopoulis S, Delalande A, Gilja OH. Sonoporation: why microbubbles create pores. Ultraschall in der Medizin 33(1), 97-98 (2012).
30. Prentice P, Cuschierp A, Dholakia K, Prausnitz M, Campbell P. Membrane disruption by optically controlled microbubble cavitation. Nat. Phys. 1(2), 107-110 (2005).
31. van Wamel A, Kooiman K, Harteveld M et al. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J. Control. Release 112(2), 149-155 (2006).
32. Duvshani-Eshet M, Machluf M. Therapeutic ultrasound optimization for gene delivery: a key factor achieving nuclear DNA localization. J. Control. Release 108(2-3), 513-528 (2005).
33. Kaddur K, Lebegue L, Tranquart F, Midoux P, Pichon C, Bouakaz A. Transient transmembrane release of green fluorescent proteins with sonoporation. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 57(7), 1558-1567 (2010).
34. Mehier-Humbert S, Bettinger T, Yan F, Guy RH. Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. J. Control. Release 104(1), 213-222 (2005).
35. Mehier-Humbert S, Bettinger T, Yan F, Guy RH. Ultrasound-mediated gene delivery: kinetics of plasmid internalization and gene expression. J. Control. Release 104(1), 203-211 (2005).
36. Ferrara KW. Driving delivery vehicles with ultrasound. Adv. Drug Deliv. Rev. 60(10), 1097-1102 (2008).
37. Unger EC, Porter T, Culp W, Labell R, Matsunaga T, Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv. Drug Deliv. Rev. 56(9), 1291-1314 (2004).
38. Krasovitski B, Frenkel V, Shoham S, Kimmel E. Intramembrane cavitation as a unifying mechanism for ultrasound-induced bioeffects. Proc. Natl Acad. Sci. USA 108(8), 3258-3263 (2011).
39. van Wamel A, Bouakaz A, Versluis M, de Jong N. Micromanipulation of endothelial cells: ultrasound-microbubble-cell interaction. Ultrasound Med. Biol. 30(9), 1255-1258 (2004).
40. Postema M, Gilja OH. Jetting does not cause sonoporation. Biomed. Eng. 55(Suppl. 1), 19-20 (2010).
41. Marmottant P, Biben T, Hilgenfeldt S. Deformation and rupture of lipid vesicles in the strong shear flow generated by ultrasound-driven microbubbles. Proc. R. Soc. A 464(2095), 1781-1800 (2008).
42. Marmottant P, Hilgenfeldt S. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature 423(6936), 153-156 (2003).
43. Frenkel V, Kimmel E, Iger Y. Ultrasound-induced intercellular space widening in fish epidermis. Ultrasound Med. Biol. 26(3), 473-480 (2000).
44. Delalande A, Kotopoulis S, Rovers T, Pichon C, Postema M. Sonoporation at a low mechanical index. Bubble Sci. Eng. Tech. 3(1), 3-11 (2011).
45. Mukherjee D, Wong J, Griffin B et al. Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration. J. Am. Coll. Cardiol. 35(6), 1678-1686 (2000).
46. Taniyama Y, Tachibana K, Hiraoka K et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 105(10), 1233-1239 (2002).
47. Zhou Y, Kumon RE, Cui J, Deng CX. The size of sonoporation pores on the cell membrane. Ultrasound Med. Biol. (2009).
48. Deng CX, Sieling F, Pan H, Cui J. Ultrasound-induced cell membrane porosity. Ultrasound Med. Biol. 30(4), 519-526 (2004).
49. Karshafian R, Bevan PD, Williams R, Samac S, Burns PN. Sonoporation by ultrasound-activated microbubble contrast agents: effect of acoustic exposure parameters on cell membrane permeability and cell viability. Ultrasound Med. Biol. 35(5), 847-860 (2009).
50. Juffermans LJ, Meijering DB, van Wamel A et al. Ultrasound and microbubble-targeted delivery of therapeutic compounds: ICIN report project 49: drug and gene delivery through ultrasound and microbubbles. Neth. Heart J. 17(2), 82-86 (2009).
51. Fan Z, Kumon RE, Park J, Deng CX. Intracellular delivery and calcium transients generated in sonoporation facilitated by microbubbles. J. Control. Release 142(1), 31-39 (2010).
52. Kumon RE, Aehle M, Sabens D et al. Spatiotemporal effects of sonoporation measured by real-time calcium imaging. Ultrasound Med. Biol. 35(3), 494-506 (2009).
53. Kumon RE, Aehle M, Sabens D, Parikh P, Kourennyi D, Deng CX. Ultrasound-induced calcium oscillations and waves in Chinese hamster ovary cells in the presence of microbubbles. Biophys. J. 93(6), L29YL31 (2007).
54. Park J, Fan Z, Deng CX. Effects of shear stress cultivation on cell membrane disruption and intracellular calcium concentration in sonoporation of endothelial cells. J. Biomech. 44(1), 164-169 (2011).
55. Paula DM, Valero-Lapchik VB, Paredes- Gamero EJ, Han SW. Therapeutic ultrasound promotes plasmid DNA uptake by clathrin-mediated endocytosis. J. Gene Med. 13(7-8), 392-401 (2011).
56. Meijering BD, Juffermans LJ, van Wamel A et al. Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ. Res. 104(5), 679-687 (2009).
57. Eliasson L, Proks P, Ammala C et al. Endocytosis of secretory granules in mouse pancreatic beta-cells evoked by transient elevation of cytosolic calcium. J. Physiol. 493 (Pt 3), 755-767 (1996).
58. MacDonald PE, Eliasson L, Rorsman P. Calcium increases endocytotic vesicle size and accelerates membrane fission in insulin-secreting INS-1 cells. J. Cell. Sci. 118(Pt 24), 5911-5920 (2005).
59. Juffermans LJ, Dijkmans PA, Musters RJ, Visser CA, Kamp O. Transient permeabilization of cell membranes by ultrasound-exposed microbubbles is related to formation of hydrogen peroxide. Am. J. Physiol. Heart Circ. Physiol. 291(4), H1595YH1601 (2006).
60. Bao S, Thrall BD, Miller DL. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med. Biol. 23(6), 953-959 (1997).
61. Miller DL, Thomas RM, Frazier ME. Ultrasonic cavitation indirectly induces single strand breaks in DNA of viable cells in vitro by the action of residual hydrogen peroxide. Ultrasound Med. Biol. 17(7), 729-735 (1991).
62. Juffermans LJ, Kamp O, Dijkmans PA, Visser CA, Musters RJ. Low-intensity ultrasound-exposed microbubbles provoke local hyperpolarization of the cell membrane via activation of BK(Ca) channels. Ultrasound Med. Biol. 34(3), 502-508 (2008).
63. Tran TA, Le Guennec JY, Bougnoux P, Tranquart F, Bouakaz A. Characterization of cell membrane response to ultrasound activated microbubbles. IEEE Trans. Ultrason. Ferroelectr. Freq. Control. 55(1), 43-49 (2008).
64. Tran TA, Roger S, Le Guennec JY, Tranquart F, Bouakaz A. Effect of ultrasound-activated microbubbles on the cell electrophysiological properties. Ultrasound Med. Biol. 33(1), 158-163 (2007).
65. Greenleaf WJ, Bolander ME, Sarkar G, Goldring MB, Greenleaf JF. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med. Biol. 24(4), 587-595 (1998).
66. Stride E, Edirisinghe M. Novel preparation techniques for controlling microbubble uniformity: a comparison. Med. Biol. Eng. Comput. 47(8), 883-892 (2009).
67. Zhao YZ, Liang HD, Mei XG, Halliwell M. Preparation, characterization and in vivo observation of phospholipid-based gas-filled microbubbles containing hirudin. Ultrasound Med. Biol. 31(9), 1237-1243 (2005).
68. Huang SL. Liposomes in ultrasonic drug and gene delivery. Adv. Drug Deliv. Rev. 60(10), 1167-1176 (2008).
69. Klibanov AL. Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging. Bioconj. Chem. 16(1), 9-17 (2005).
70. Aoi A, Watanabe Y, Mori S, Takahashi M, Vassaux G, Kodama T. Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound. Ultrasound Med. Biol. 34(3), 425-434 (2008).
71. Lentacker I, Geers B, Demeester J, De Smedt SC, Sanders NN. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol. Ther. 18(1), 101-108 (2010).
72. Ibsen S, Benchimol M, Simberg D, Schutt C, Steiner J, Esener S. A novel nested liposome drug delivery vehicle capable of ultrasound triggered release of its payload. J. Control. Release 155(3), 358-366 (2011).
73. Lee H, Pastor RW. Coarse-grained model for PEGylated lipids: effect of PEGylation on the size and shape of self-assembled structures. J.Phys. Chem. B 115(24), 7830-7837 (2011).
74. Suzuki R, Takizawa T, Negishi Y, Utoguchi N, Maruyama K. Effective gene delivery with liposomal bubbles and ultrasound as novel non-viral system. J. Drug Target. 15(7-8), 531-537 (2007).
75. Un K, Kawakami S, Suzuki R, Maruyama K, Yamashita F, Hashida M. Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy. Biomaterials 31(30), 7813-7826 (2010).
76. Kheirolomoom A, Dayton PA, Lum AF et al. Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. J. Control. Release 118(3), 275-284 (2007).
77. Klibanov AL. Ultrasound molecular imaging with targeted microbubble contrast agents. J. Nucl. Cardiol. 14(6), 876-884 (2007).
78. Lindner JR, Song J, Christiansen J, Klibanov AL, Xu F, Ley K. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 104(17), 2107-2112 (2001).
79. Anderson CR, Rychak JJ, Backer M, Backer J, Ley K, Klibanov AL. scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis. Invest. Radiol. 45(10), 579-585 (2010).
80. Anwer K, Kao G, Proctor B et al. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther. 7(21), 1833-1839 (2000).
81. Vannan M, McCreery T, Li P et al. Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. J. Am. Soc. Echocardiogr. 15(3), 214-218 (2002).
82. Christiansen JP, French BA, Klibanov AL, Kaul S, Lindner Jr. Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med. Biol. 29(12), 1759-1767 (2003).
83. Hayashi S, Mizuno M, Yoshida J, Nakao A. Effect of sonoporation on cationic liposome-mediated IFNbeta gene therapy for metastatic hepatic tumors of murine colon cancer. Cancer Gene Ther. 16(8), 638-643 (2009).
84. Tlaxca JL, Anderson CR, Klibanov AL et al. Analysis of in vitro transfection by sonoporation using cationic and neutral microbubbles. Ultrasound Med. Biol. 36(11), 1907-1918 (2010).
85. Lentacker I, De Geest BG, Vandenbroucke RE et al. Ultrasound-responsive polymer-coated microbubbles that bind and protect DNA. Langmuir 22(17), 7273-7278 (2006).
86. Borden MA, Caskey CF, Little E, Gillies RJ, Ferrara KW. DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles. Langmuir 23(18), 9401-9408 (2007).
87. Vandenbroucke RE, Lentacker I, Demeester J, De Smedt SC, Sanders NN. Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles. J. Control. Release 126(3), 265-273 (2008).
88. Sirsi SR, Hernandez SL, Zielinski L et al. Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. J. Control. Release 157(2), 224-234 (2012).
89. Suzuki R, Maruyama K. Effective in vitro and in vivo gene delivery by the combination of liposomal bubbles (bubble liposomes) and ultrasound exposure. Methods Mol. Biol. 605, 473-486 (2010).
90. Suzuki R, Takizawa T, Negishi Y et al. Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound. J. Control. Release 117(1), 130-136 (2007).
91. Suzuki R, Takizawa T, Negishi Y, Utoguchi N, Maruyama K. Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology. Int. J. Pharm. 354(1-2), 49-55 (2008).
92. Suzuki R, Namai E, Oda Y et al. Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. J. Control. Release 142(2), 245-250 (2010).
93. Suzuki R, Takizawa T, Negishi Y et al. Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles. J. Control. Release 125(2), 137-144 (2008).
94. Newman CM, Bettinger T. Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther. 14(6), 465-475 (2007).
95. Pichon C, Kaddur K, Midoux P, Tranquart F, Bouakaz A. Recent advances in gene delivery with ultrasound and microbubbles. J. Exp. Nanosci. 3(1), 17-40 (2008).
96. Suzuki R, Oda Y, Utoguchi N, Maruyama K. Progress in the development of ultrasound-mediated gene delivery systems utilizing nano- and microbubbles. J. Control. Release 149(1), 36-41 (2011).
97. Haag P, Frauscher F, Gradl J et al. Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours. J. Steroid Biochem. Mol. Biol. 102(1-5), 103-113 (2006).
98. Kim HJ, Greenleaf JF, Kinnick RR, Bronk JT, Bolander ME. Ultrasound-mediated transfection of mammalian cells. Hum. Gene Ther. 7(11), 1339-1346 (1996).
99. Huber PE, Pfisterer P. In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound. Gene Ther. 7(17), 1516-1525 (2000).
100. Huber PE, Mann MJ, Melo LG et al. Focused ultrasound (HIFU) induces localized enhancement of reporter gene expression in rabbit carotid artery. Gene Ther. 10(18), 1600-1607 (2003).
101. Huber PE, Jenne J, Debus J, Wannenmacher MF, Pfisterer P. A comparison of shock wave and sinusoidal-focused ultrasound-induced localized transfection of HeLa cells. Ultrasound Med. Biol. 25(9), 1451-1457 (1999).
102. Li T, Tachibana K, Kuroki M. Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice Y initial results. Radiology 229(2), 423-428 (2003).
103. Chen S, Shohet RV, Bekeredjian R, Frenkel P, Grayburn PA. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J. Am. Coll. Cardiol. 42(2), 301-308 (2003).
104. Bekeredjian R, Chen S, Frenkel PA, Grayburn PA, Shohet RV. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 108(8), 1022-1026 (2003).
105. Kondo I, Ohmori K, Oshita A et al. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction. J. Am. Coll. Cardiol. 44(3), 644-653 (2004).
106. Leong-Poi H, Kuliszewski MA, Lekas M et al. Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ. Res. 101(3), 295-303 (2007).
107. Kobulnik J, Kuliszewski MA, Stewart DJ, Lindner JR, Leong-Poi H. Comparison of gene delivery techniques for therapeutic angiogenesis ultrasound-mediated destruction of carrier microbubbles versus direct intramuscular injection. J. Am. Coll. Cardiol. 54(18), 1735-1742 (2009).
108. Fujii H, Sun Z, Li SH et al. Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice. JACC Cardiovasc. Imaging 2(7), 869-879 (2009).
109. Fujii H, Li SH, Wu J et al. Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair. Eur. Heart J. 32(16), 2075-2084 (2011).
110. Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat. Biotechnol. 16(3), 247-252 (1998).
111. Nakashima M, Tachibana K, Iohara K, Ito M, Ishikawa M, Akamine A. Induction of reparative dentin formation by ultrasound-mediated gene delivery of growth/ differentiation factor 11. Hum. Gene Ther. 14(6), 591-597 (2003).
112. Sheyn D, Kimelman-Bleich N, Pelled G, Zilberman Y, Gazit D, Gazit Z. Ultrasound-based nonviral gene delivery induces bone formation in vivo. Gene Ther. 15(4), 257-266 (2007).
113. Yang RS, Lin WL, Chen YZ et al. Regulation by ultrasound treatment on the integrin expression and differentiation of osteoblasts. Bone 36(2), 276-283 (2005).
114. Osawa K, Okubo Y, Nakao K, Koyama N, Bessho K. Osteoinduction by microbubble-enhanced transcutaneous sonoporation of human bone morphogenetic protein-2. J. Gene Med. 11(7), 633-641 (2009).
115. Katagiri T, Yamaguchi A, Ikeda T et al. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem. Biophys. Res. Commun. 172(1), 295-299 (1990).
116. Andersson GB. Epidemiological features of chronic low-back pain. Lancet 354(9178), 581-585 (1999).
117. Freemont AJ, Peacock TE, Goupille P, Hoyland JA, O'Brien J, Jayson MI. Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet 350(9072), 178-181 (1997).
118. Nishida K, Doita M, Takada T et al. Sustained transgene expression in intervertebral disc cells in vivo mediated by microbubble-enhanced ultrasound gene therapy. Spine 31(13), 1415-1419 (2006).
119. Suzuki T, Nishida K, Kakutani K et al. Sustained long-term RNA interference in nucleus pulposus cells in vivo mediated by unmodified small interfering RNA. Eur. Spine J. 18(2), 263-270 (2009).
120. Delalande A, Bouakaz A, Renault G et al. Ultrasound and microbubble-assisted gene delivery in Achilles tendons: long lasting gene expression and restoration of fibromodulin KO phenotype. J. Control. Release 156(2), 223-230 (2011).
121. Delalande A, Bureau MF, Midoux P, Bouakaz A, Pichon C. Ultrasound-assisted microbubbles gene transfer in tendons for gene therapy. Ultrasonics, 50(2), 269-272 (2010).
122. Lou J. In vivo gene transfer into tendon by recombinant adenovirus. Clin. Orthop. Relat. Res. (Suppl. 379), S252YS255 (2000).
123. Glover DJ, Lipps HJ, Jans DA. Towards safe, non-viral therapeutic gene expression in humans. Nat. Rev. 6(4), 299-310 (2005).
124. Duvshani-Eshet M, Benny O, Morgenstern A, Machluf M. Therapeutic ultrasound facilitates antiangiogenic gene delivery and inhibits prostate tumor growth. Mol. Cancer Ther. 6(8), 2371-2382 (2007).
125. Duvshani-Eshet M, Machluf M. Efficient transfection of tumors facilitated by long-term therapeutic ultrasound in combination with contrast agent: from in vitro to in vivo setting. Cancer Gene Ther. 14(3), 306-315 (2007).
126. Collins CG, Tangney M, Larkin JO et al. Local gene therapy of solid tumors with GM-CSF and B7-1 eradicates both treated and distal tumors. Cancer Gene Ther. 13(12), 1061-1071 (2006).
127. Craig R, Cutrera J, Zhu S, Xia X, Lee YH, Li S. Administering plasmid DNA encoding tumor vessel-anchored IFN-alpha for localizing gene product within or into tumors. Mol. Ther. 16(5), 901-906 (2008).
128. Hauff P, Seemann S, Reszka R et al. Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models. Radiology 236(2), 572-578 (2005).
129. Iwanaga K, Tominaga K, Yamamoto K et al. Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Ther. 14(4), 354-363 (2007).
130. Li YS, Davidson E, Reid CN, McHale AP. Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: potential applications for gene therapy of cancer. Cancer Lett. 273(1), 62-69 (2009).
131. Sato M, O'Gara P, Harding SE, Fuller SJ. Enhancement of adenoviral gene transfer to adult rat cardiomyocytes in vivo by immobilization and ultrasound treatment of the heart. Gene Ther. 12(11), 936-941 (2005).
132. Howard CM, Forsberg F, Minimo C, Liu JB, Merton DA, Claudio PP. Ultrasound guided site specific gene delivery system using adenoviral vectors and commercial ultrasound contrast agents. J. Cell. Physiol. 209(2), 413-421 (2006).
133. Guo Z, Hong S, Jin X, Luo Q, Wang Z, Wang Y. Study on the multidrug resistance 1 gene transfection efficiency using adenovirus vector enhanced by ultrasonic microbubbles in vitro. Mol. Biotechnol. 48(2), 138-146 (2011).
134. Alter J, Sennoga CA, Lopes DM, Eckersley RJ, Wells DJ. Microbubble stability is a major determinant of the efficiency of ultrasound and microbubble mediated in vivo gene transfer. Ultrasound Med Biol, 35(6), 976-984 (2009).
135. Muller OJ, Schinkel S, Kleinschmidt JA, Katus HA, Bekeredjian R. Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats. Gene Ther. 15(23), 1558-1565 (2008).
136. Bekeredjian R, Chen S, Pan W, Grayburn PA, Shohet RV. Effects of ultrasound-targeted microbubble destruction on cardiac gene expression. Ultrasound Med. Biol. 30(4), 539-543 (2004).
137. Chen S, Kroll MH, Shohet RV, Frenkel P, Mayer SA, Grayburn PA. Bioeffects of myocardial contrast microbubble destruction by echocardiography. Echocardiography 19(6), 495-500 (2002).
138. Martin KR, Klein RL, Quigley HA. Gene delivery to the eye using adeno-associated viral vectors. Methods 28(2), 267-275 (2002).
139. Negrete A, Kotin RM. Strategies for manufacturing recombinant adeno-associated virus vectors for gene therapy applications exploiting baculovirus technology. Brief Funct. Genomic Proteomic 7(4), 303-311 (2008).
140. Touchard E, Kowalczuk L, Bloquel C, Naud MC, Bigey P, Behar-Cohen F. The ciliary smooth muscle electrotransfer: basic principles and potential for sustained intraocular production of therapeutic proteins. J. Gene Med. 12(11), 904-919 (2010).
141. Xie W, Liu S, Su H, Wang Z, Zheng Y, Fu Y. Ultrasound microbubbles enhance recombinant adeno-associated virus vector delivery to retinal ganglion cells in vivo. Acad. Radiol. 17(10), 1242-1248 (2010).
142. Levin LA, Schlamp CL, Spieldoch RL, Geszvain KM, Nickells RW. Identification of the bcl-2 family of genes in the rat retina. Invest. Ophthalmol. Vis. Sci. 38(12), 2545-2553 (1997).
143. Dang SP, Wang RX, Qin MD et al. A novel transfection method for eukaryotic cells using polyethylenimine coated albumin microbubbles. Plasmid 66(1), 19-25 (2011).
144. Deshpande MC, Prausnitz MR. Synergistic effect of ultrasound and PEI on DNA transfection in vitro. J. Control. Release 118(1), 126-135 (2007).
145. Qiu Y, Luo Y, Zhang Y et al. The correlation between acoustic cavitation and sonoporation involved in ultrasound-mediated DNA transfection with polyethylenimine (PEI) in vitro. J. Control. Release 145(1), 40-48 (2010).
146. Chen ZY, Liang K, Qiu RX. Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit survivin gene expression and induce apoptosis. J. Exp. Clin. Cancer Res. 29, 152 (2010).
147. Lu QL, Liang HD, Partridge T, Blomley MJ. Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage. Gene Ther. 10(5), 396-405 (2003).
148. Xenariou S, Griesenbach U, Liang HD et al. Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Ther. 14(9), 768-774 (2007).
149. ter Haar G, Shaw A, Pye S et al. Guidance on reporting ultrasound exposure conditions for bio-effects studies. Ultrasound Med. Biol. 37(2), 177-183 (2011).
150. Pichon C, Billiet L, Midoux P. Chemical vectors for gene delivery: uptake and intracellular trafficking. Curr. Opin. Biotechnol. 21(5), 640-645 (2010).
151. Harraghy N, Gaussin A, Mermod N. Sustained transgene expression using MAR elements. Curr. Gene Ther. 8(5), 353-366 (2008).